by Market Overview:
Pharmaceutical traceability refers to the ability to track the whole lifecycle of pharmaceutical products including raw materials, packaging, manufacturing & distribution. It helps to identify the origin and current location of drugs through all stages of production, distribution, and sale.
The pharmaceutical traceability market is estimated to be valued at US$ 4.3 Bn or Billion in 2023 and is expected to exhibit a CAGR of 10% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
Increasing focus on supply chain visibility is one of the major trends seen in the pharmaceutical traceability market. Pharmaceutical companies are strengthening traceability systems to improve visibility across complex global supply chains. This helps them to quickly identify and quarantine potentially unsafe or compromised drugs. Advanced serialization and aggregation is further enabling full traceability of products right from raw material to the end consumer. Blockchain technology is also being explored to enhance traceability and build transparency in pharmaceutical supply chains.
SWOT Analysis
Strength: The pharmaceutical traceability market has strong regulations and compliance requirements in place which drives the need for traceability solutions. This regulatory push acts as a strength for the market.
Weakness: High initial costs associated with implementing traceability solutions can be a weakness for small pharma companies. Additionally, lack of standardized traceability practices across regions poses an interoperability challenge.
Opportunity: Emerging trends like blockchain provide an opportunity to further enhance traceability and security of supply chains. Real-time track and trace of medications can also improve patient outcomes.
Threats: Security threats like counterfeiting and stakeholder access to sensitive data are challenges. Lack of adoption in developing nations is also a threat for long term market growth.
Key Takeaways
The Global Pharmaceutical Traceability Market Size is expected to witness high growth, exhibiting CAGR of 10% over the forecast period, due to increasing regulatory compliance requirements globally. Stringent laws and protocols around drug safety bolster demand.
Regional analysis: North America dominated the market in 2023, accounting for over 30% share. This is attributed to well established regulations and early adoption among pharma players. Asia Pacific is anticipated to exhibit fastest growth through 2030 amid rising healthcare spends and growing importance given to drug authenticity in major economies like India and China.
Key players operating in the pharmaceutical traceability market are SAP SE, Oracle Corporation, IBM Corporation, Microsoft Corporation, SAS Institute Inc., Infor, JDA Software, TraceLink, GS1, Owens & Minor. These suppliers offer packaging, labelling, serialization and aggregation solutions tailored for pharma supply chain environments. Strategic partnerships for traceability network development are on the rise in the competitive space.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
